Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
Johnson & Johnson is relaunching sales of a promising heart-rhythm device after a safety scare, but with a new warning for doctors that analysts say could hamper its market potential ...
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the healthcare field. Valued at a market cap of $366.3 billion, the company ...
Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...
Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...
Medical-technology and drug company's 2025 sales outlook is below consensus Johnson & Johnson's stock ... from Dow Jones Newswires and The Wall Street Journal. We sell different types of products ...
Buckhead Capital Management LLC trimmed its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.0% in the fourth ...
Chevy Chase Trust Holdings LLC lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.3% during the ...
Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.
New Brunswick, New Jersey-based Johnson & Johnson (JNJ ... s earnings surprise history is promising. It surpassed the Wall Street estimates in each of the last four quarters.